Skip to main content

The Leukemia & Lymphoma Society Still Reins “Superior” in Independent Analysis of Chronic Disease Nonprofits

By LLS Staff

LLS continues to sustain bold progress, maintaining Cause Reports highest score and earned an esteemed "Superior" rating in its new, independent analysis of eight of the largest chronic disease organizations, recognized notably for its mission-driven "innovative programs" and "well-documented impact." LLS is proud that Cause Reports, the next level of charity reviews, affirms that your support will help blood cancer patients survive and thrive.

Cause Reports' analyses of nonprofits focus on outcomes and provide a holistic view of each organization, generating a score based on how they operate against the challenges of mission, fundraising, finances, and governance. This latest acknowledgment is another testament to our commitment to our mission to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.

To view the entire report, please click here.

At a time when there are so many ways to give, no matter how you choose to support those affected by blood cancers – by donating, fundraising or volunteering – you can give to LLS confidently and know that your support has an impact.
 

Related Blog Posts

A scientist using a pipette with a microtiter plate and a petri dish

CAR T-cell therapy: A step-by-step guide for patients and families

A patient-friendly guide to CAR-T, including treatment steps, side effects, and recovery.

3D image of red blood cells with cancer cells

What is a bone marrow transplant? A patient-friendly guide to bone marrow transplantation

Learn what to expect before, during, and after a bone marrow transplant.

troywilson-002.jpg

Behind the breakthroughs - menin inhibitors: A conversation with Troy Wilson, PhD, JD

Dr. Kolb and Dr. Wilson discuss the journey of menin inhibitors in treating acute myeloid leukemia (AML).

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.